SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,706,600 | -25.4% | 780,000 | 0.0% | 0.18% | -17.1% |
Q2 2023 | $3,627,000 | -55.8% | 780,000 | -56.1% | 0.22% | -63.5% |
Q1 2023 | $8,207,333 | -42.8% | 1,776,479 | 0.0% | 0.59% | -33.4% |
Q4 2022 | $14,353,950 | +45.6% | 1,776,479 | 0.0% | 0.89% | +17.5% |
Q3 2022 | $9,859,000 | +6.5% | 1,776,479 | 0.0% | 0.76% | -13.1% |
Q2 2022 | $9,255,000 | -36.6% | 1,776,479 | 0.0% | 0.87% | -29.9% |
Q1 2022 | $14,603,000 | – | 1,776,479 | – | 1.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |